S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
NASDAQ:ALGN

Align Technology Stock Forecast, Price & News

$475.50
+1.81 (+0.38 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$468.14
Now: $475.50
$477.17
50-Day Range
$326.84
MA: $423.51
$491.91
52-Week Range
$127.88
Now: $475.50
$507.05
Volume247,975 shs
Average Volume961,107 shs
Market Capitalization$37.49 billion
P/E Ratio21.63
Dividend YieldN/A
Beta1.75
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California.
Read More
Align Technology logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.85 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-470-1000
Employees14,530

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.41 billion
Cash Flow$6.04 per share
Book Value$38.47 per share

Profitability

Net Income$442.78 million

Miscellaneous

Market Cap$37.49 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$475.50
+1.81 (+0.38 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALGN News and Ratings via Email

Sign-up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Align Technology (NASDAQ:ALGN) Frequently Asked Questions

How has Align Technology's stock price been impacted by COVID-19 (Coronavirus)?

Align Technology's stock was trading at $202.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ALGN shares have increased by 135.2% and is now trading at $475.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Align Technology?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 1 sell rating, 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Align Technology
.

What stocks does MarketBeat like better than Align Technology?

Wall Street analysts have given Align Technology a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Align Technology wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Align Technology's next earnings date?

Align Technology is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Align Technology
.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) announced its earnings results on Wednesday, October, 21st. The medical equipment provider reported $2.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.23 by $2.02. The medical equipment provider had revenue of $734.14 million for the quarter, compared to analysts' expectations of $551.55 million. Align Technology had a net margin of 76.00% and a return on equity of 68.99%. Align Technology's revenue was up 20.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.28 earnings per share.
View Align Technology's earnings history
.

What price target have analysts set for ALGN?

14 equities research analysts have issued twelve-month price objectives for Align Technology's stock. Their forecasts range from $165.00 to $535.00. On average, they anticipate Align Technology's share price to reach $411.23 in the next twelve months. This suggests that the stock has a possible downside of 13.5%.
View analysts' price targets for Align Technology
.

Are investors shorting Align Technology?

Align Technology saw a decrease in short interest in October. As of October 30th, there was short interest totaling 2,020,000 shares, a decrease of 22.3% from the October 15th total of 2,600,000 shares. Based on an average daily volume of 751,700 shares, the days-to-cover ratio is presently 2.7 days. Currently, 2.8% of the company's stock are short sold.
View Align Technology's Short Interest
.

Who are some of Align Technology's key competitors?

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), salesforce.com (CRM), Mastercard (MA) and Tesla (TSLA).

Who are Align Technology's key executives?

Align Technology's management team includes the following people:
  • Mr. Joseph M. Hogan, Pres, CEO & Director (Age 63)
  • Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 53)
  • Mr. Emory M. Wright, Sr. VP of Global Operations (Age 50, Pay $1.09M)
  • Mr. Vamsi Mohan-Raj Pudipeddi, Sr. VP and Chief Product, Innovation & Marketing Officer (Age 48, Pay $1.13M)
  • Ms. Julie Tay, Sr. VP & MD of Asia Pacific (Age 53, Pay $1.21M)
  • Mr. Zelko Relic, Sr. VP & Chief Technology Officer (Age 55)
  • Ms. Shirley Stacy, VP of Corp. Communications & Investor Relations
  • Ms. Julie Ann Coletti, Sr. VP and Chief Legal & Regulatory Officer
  • Mr. Stuart Hockridge, Sr. VP of Global HR (Age 48)
  • Mr. Simon Beard, MD for Americas Region & Sr. VP (Age 53)

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.98%), Sands Capital Management LLC (3.91%), State Street Corp (3.90%), Bares Capital Management Inc. (1.49%), Wells Fargo & Company MN (1.24%) and Allianz Asset Management GmbH (1.11%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, George J Morrow, Greg J Santora, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends for Align Technology
.

Which institutional investors are selling Align Technology stock?

ALGN stock was sold by a variety of institutional investors in the last quarter, including Bares Capital Management Inc., Epoch Investment Partners Inc., Los Angeles Capital Management & Equity Research Inc., Nuveen Asset Management LLC, Allianz Asset Management GmbH, UBS Asset Management Americas Inc., Ziegler Capital Management LLC, and Sands Capital Management LLC. Company insiders that have sold Align Technology company stock in the last year include Emory Wright, George J Morrow, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Simon Beard, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked, and Zelko Relic.
View insider buying and selling activity for Align Technology
.

Which institutional investors are buying Align Technology stock?

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Massachusetts Financial Services Co. MA, Polar Capital LLP, Polar Capital LLP, Lord Abbett & CO. LLC, State of Michigan Retirement System, First Trust Advisors LP, and Point72 Asset Management L.P.. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan, and Vamsi Mohan Raj Pudipeddi.
View insider buying and selling activity for Align Technology
.

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $475.50.

How big of a company is Align Technology?

Align Technology has a market capitalization of $37.49 billion and generates $2.41 billion in revenue each year. The medical equipment provider earns $442.78 million in net income (profit) each year or $4.96 on an earnings per share basis. Align Technology employs 14,530 workers across the globe.

What is Align Technology's official website?

The official website for Align Technology is www.aligntech.com.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.